{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T11:41:59Z","timestamp":1789990919654,"version":"4.0.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,3,31]],"date-time":"2017-03-31T00:00:00Z","timestamp":1490918400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,3,31]],"date-time":"2017-03-31T00:00:00Z","timestamp":1490918400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81070963"],"award-info":[{"award-number":["81070963"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2010HM019"],"award-info":[{"award-number":["ZR2010HM019"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Torbj\u00f8rg Hauges\u2019 Legacy"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1007\/s00415-017-8478-z","type":"journal-article","created":{"date-parts":[[2017,3,31]],"date-time":"2017-03-31T09:01:54Z","timestamp":1490950914000},"page":"955-962","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["RETRACTED ARTICLE: Juvenile-onset myasthenia gravis: autoantibody status, clinical characteristics and genetic polymorphisms"],"prefix":"10.1007","volume":"264","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3125-2855","authenticated-orcid":false,"given":"Yu","family":"Hong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geir Olve","family":"Skeie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paraskevi","family":"Zisimopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina","family":"Karagiorgou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Socrates J.","family":"Tzartos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao-Xian","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik","family":"Romi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils Erik","family":"Gilhus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,31]]},"reference":[{"key":"8478_CR1","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.ejrad.2014.11.042","volume":"84","author":"JB Ackman","year":"2015","unstructured":"Ackman JB, Verzosa S, Kovach AE, Louissaint A Jr, Lanuti M, Wright CD, Shepard JA, Halpern EF (2015) High rate of unnecessary thymectomy and its cause. Can computed tomography distinguish thymoma, lymphoma, thymic hyperplasia, and thymic cysts? Eur J Radiol 84:524\u2013533","journal-title":"Eur J Radiol"},{"key":"8478_CR2","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jaut.2013.12.001","volume":"52","author":"N Avidan","year":"2014","unstructured":"Avidan N, Le Panse R, Berrih-Aknin S, Miller A (2014) Genetic basis of myasthenia gravis\u2014a comprehensive review. J Autoimmun 52:146\u2013153","journal-title":"J Autoimmun"},{"key":"8478_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2014.05.001","volume":"52","author":"S Berrih-Aknin","year":"2014","unstructured":"Berrih-Aknin S (2014) Myasthenia gravis: paradox versus paradigm in autoimmunity. J Autoimmun 52:1\u201328","journal-title":"J Autoimmun"},{"key":"8478_CR4","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jaut.2013.12.011","volume":"52","author":"S Berrih-Aknin","year":"2014","unstructured":"Berrih-Aknin S, Le Panse R (2014) Myasthenia gravis: a comprehensive review of immune dysregulation and etiological mechanisms. J Autoimmun 52:90\u2013100","journal-title":"J Autoimmun"},{"key":"8478_CR5","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1111\/j.1538-7836.2012.04815.x","volume":"10","author":"X Chen","year":"2012","unstructured":"Chen X, Li S, Yang Y, Yang X, Liu Y, Liu Y, Hu W, Jin L, Wang X (2012) Genome-wide association study validation identifies novel loci for atherosclerotic cardiovascular disease. J Thromb Haemost 10:1508\u20131514","journal-title":"J Thromb Haemost"},{"key":"8478_CR6","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1055\/s-0034-1390532","volume":"45","author":"A Della Marina","year":"2014","unstructured":"Della Marina A, Trippe H, Lutz S, Schara U (2014) Juvenile myasthenia gravis: recommendations for diagnostic approaches and treatment. Neuropediatrics 45:75\u201383","journal-title":"Neuropediatrics"},{"key":"8478_CR7","first-page":"404101","volume":"2011","author":"MF Finnis","year":"2011","unstructured":"Finnis MF, Jayawant S (2011) Juvenile myasthenia gravis: a paediatric perspective. Autoimmune Dis 2011:404101","journal-title":"Autoimmune Dis"},{"key":"8478_CR8","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/0167-5699(96)80543-3","volume":"17","author":"AJT George","year":"1996","unstructured":"George AJT, Ritter MA (1996) Thymic involution with ageing: obsolescence or good housekeeping? Immunol Today 17:267\u2013272","journal-title":"Immunol Today"},{"key":"8478_CR9","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nrneurol.2016.44","volume":"12","author":"NE Gilhus","year":"2016","unstructured":"Gilhus NE, Skeie GO, Romi F, Lazaridis K, Zisimopoulou P, Tzartos S (2016) Myasthenia gravis\u2014autoantibody characteristics and their implications for therapy. Nat Rev Neurol 12:259\u2013268","journal-title":"Nat Rev Neurol"},{"key":"8478_CR10","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S1474-4422(15)00145-3","volume":"14","author":"NE Gilhus","year":"2015","unstructured":"Gilhus NE, Verschuuren JJ (2015) Myasthenia gravis: subgroup classification and therapeutic strategies. Lancet Neurol 14:1023\u20131036","journal-title":"Lancet Neurol"},{"key":"8478_CR11","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1038\/nature06066","volume":"448","author":"M Giraud","year":"2007","unstructured":"Giraud M, Taubert R, Vandiedonck C, Ke X, Levi-Strauss M, Pagani F, Baralle FE, Eymard B, Tranchant C, Gajdos P, Vincent A, Willcox N, Beeson D, Kyewski B, Garchon HJ (2007) An IRF8-binding promoter variant and AIRE control CHRNA1 promiscuous expression in thymus. Nature 448:934\u2013937","journal-title":"Nature"},{"key":"8478_CR12","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1006\/jaut.1996.0021","volume":"9","author":"JM Heckmann","year":"1996","unstructured":"Heckmann JM, Morrison KE, Emeryk-Szajewska B, Strugalska H, Bergoffen J, Willcox N, Newsom-Davis J (1996) Human muscle acetylcholine receptor alpha-subunit gene (CHRNA1) association with autoimmune myasthenia gravis in black, mixed-ancestry and Caucasian subjects. J Autoimmun 9:175\u2013180","journal-title":"J Autoimmun"},{"key":"8478_CR13","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jneuroim.2016.07.001","volume":"298","author":"Y Hong","year":"2016","unstructured":"Hong Y, Li H-F, Skeie GO, Romi F, Hao H-J, Zhang X, Gao X, Owe JF, Gilhus NE (2016) Autoantibody profile and clinical characteristics in a cohort of Chinese adult myasthenia gravis patients. J Neuroimmunol 298:51\u201357","journal-title":"J Neuroimmunol"},{"key":"8478_CR14","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S0003-4975(00)01595-2","volume":"70","author":"A Jaretzki 3rd","year":"2000","unstructured":"Jaretzki A 3rd, Barohn RJ, Ernstoff RM, Kaminski HJ, Keesey JC, Penn AS, Sanders DB (2000) Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Ann Thorac Surg 70:327\u2013334","journal-title":"Ann Thorac Surg"},{"key":"8478_CR15","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1001\/jamaneurol.2016.2277","volume":"73","author":"HJ Kaminski","year":"2016","unstructured":"Kaminski HJ (2016) Seronegative Myasthenia gravis\u2014a vanishing disorder? JAMA Neurol 73:1055\u20131056","journal-title":"JAMA Neurol"},{"key":"8478_CR16","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jns.2016.02.031","volume":"363","author":"T Kanai","year":"2016","unstructured":"Kanai T, Uzawa A, Kawaguchi N, Sakamaki T, Yoshiyama Y, Himuro K, Oda F, Kuwabara S (2016) HLA-DRB1*14 and DQB1*05 are associated with Japanese anti-MuSK antibody-positive myasthenia gravis patients. J Neurol Sci 363:116\u2013118","journal-title":"J Neurol Sci"},{"key":"8478_CR17","doi-asserted-by":"publisher","first-page":"893","DOI":"10.2353\/ajpath.2007.070240","volume":"171","author":"MI Leite","year":"2007","unstructured":"Leite MI, Jones M, Strobel P, Marx A, Gold R, Niks E, Verschuuren JJ, Berrih-Aknin S, Scaravilli F, Canelhas A, Morgan BP, Vincent A, Willcox N (2007) Myasthenia gravis thymus: complement vulnerability of epithelial and myoid cells, complement attack on them, and correlations with autoantibody status. Am J Pathol 171:893\u2013905","journal-title":"Am J Pathol"},{"key":"8478_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-016-0024-y","author":"HF Li","year":"2016","unstructured":"Li HF, Hong Y, Zhang X, Xie Y, Skeie GO, Hao HJ, Gilhus NE, Liang B, Yue YX, Zhang XJ, Gao X, Wang Q, Gao Z, Ding XJ, Song M (2016) Gene Polymorphisms for both auto-antigen and immune-modulating proteins are associated with the susceptibility of autoimmune myasthenia gravis. Mol Neurobiol. doi:\n                    10.1007\/s12035-016-0024-y","journal-title":"Mol Neurobiol"},{"key":"8478_CR19","doi-asserted-by":"publisher","first-page":"17317","DOI":"10.1038\/srep17317","volume":"5","author":"W Li","year":"2015","unstructured":"Li W, Long C, Renjun L, Zhangxue H, Yin H, Wanwei L, Juan M, Yuan S (2015) Association of SCNN1A single nucleotide polymorphisms with neonatal respiratory distress syndrome. Sci Rep 5:17317","journal-title":"Sci Rep"},{"key":"8478_CR20","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/j.1749-6632.2012.06842.x","volume":"1274","author":"RP Lisak","year":"2012","unstructured":"Lisak RP, Ragheb S (2012) The role of B cell-activating factor in autoimmune myasthenia gravis. Ann N Y Acad Sci 1274:60\u201367","journal-title":"Ann N Y Acad Sci"},{"key":"8478_CR21","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.autrev.2013.03.007","volume":"12","author":"A Marx","year":"2013","unstructured":"Marx A, Pfister F, Schalke B, Saruhan-Direskeneli G, Melms A, Strobel P (2013) The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes. Autoimmun Rev 12:875\u2013884","journal-title":"Autoimmun Rev"},{"key":"8478_CR22","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.pediatrneurol.2014.12.006","volume":"52","author":"M Motobayashi","year":"2015","unstructured":"Motobayashi M, Inaba Y, Nishimura T, Kobayashi N, Nakazawa Y, Koike K (2015) An increase in circulating B cell-activating factor in childhood-onset ocular myasthenia gravis. Pediatr Neurol 52:404\u2013409","journal-title":"Pediatr Neurol"},{"key":"8478_CR23","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/jhg.2015.146","volume":"61","author":"M Nel","year":"2016","unstructured":"Nel M, Buys JM, Rautenbach R, Mowla S, Prince S, Heckmann JM (2016) The African-387 C>T TGFB1 variant is functional and associates with the ophthalmoplegic complication in juvenile myasthenia gravis. J Hum Genet 61:307\u2013316","journal-title":"J Hum Genet"},{"key":"8478_CR24","first-page":"44","volume":"101","author":"V Neretin","year":"2001","unstructured":"Neretin V, Serova LD, Agafonov BV, Tsuman VG, Gekht BM, Sidorova OP, Nalivkin AE (2001) Antigens of histocompatibility in children with myasthenia gravis. Zhurnal Nevrol Psikhiatrii Imeni SS Korsakova 101:44\u201348","journal-title":"Zhurnal Nevrol Psikhiatrii Imeni SS Korsakova"},{"key":"8478_CR25","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1034\/j.1600-0455.2002.430407.x","volume":"43","author":"T Pirronti","year":"2002","unstructured":"Pirronti T, Rinaldi P, Batocchi AP, Evoli A, Di Schino C, Marano P (2002) Thymic lesions and myasthenia gravis. Diagnosis based on mediastinal imaging and pathological findings. Acta Radiol 43:380\u2013384","journal-title":"Acta Radiol"},{"key":"8478_CR26","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1093\/bioinformatics\/19.1.149","volume":"19","author":"S Purcell","year":"2003","unstructured":"Purcell S, Cherny SS, Sham PC (2003) Genetic power calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 19:149\u2013150","journal-title":"Bioinformatics"},{"key":"8478_CR27","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1086\/519795","volume":"81","author":"S Purcell","year":"2007","unstructured":"Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81:559\u2013575","journal-title":"Am J Hum Genet"},{"key":"8478_CR28","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1001\/jamaneurol.2014.4103","volume":"72","author":"AE Renton","year":"2015","unstructured":"Renton AE, Pliner HA, Provenzano C et al (2015) A Genome-wide association study of myasthenia gravis. JAMA Neurol 72:396\u2013404","journal-title":"JAMA Neurol"},{"key":"8478_CR29","doi-asserted-by":"publisher","first-page":"e101986","DOI":"10.1371\/journal.pone.0101986","volume":"9","author":"L Sun","year":"2014","unstructured":"Sun L, Meng Y, Xie Y, Zhang H, Zhang Z, Wang X, Jiang B, Li W, Li Y, Yang Z (2014) CTLA4 variants and haplotype contribute genetic susceptibility to myasthenia gravis in northern Chinese population. PLoS One 9:e101986","journal-title":"PLoS One"},{"key":"8478_CR30","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1146\/annurev.immunol.24.021605.090535","volume":"24","author":"WA Teft","year":"2006","unstructured":"Teft WA, Kirchhof MG, Madrenas J (2006) A molecular perspective of CTLA-4 function. Annu Rev Immunol 24:65\u201397","journal-title":"Annu Rev Immunol"},{"key":"8478_CR31","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jneuroim.2015.04.015","volume":"284","author":"AI Tsonis","year":"2015","unstructured":"Tsonis AI, Zisimopoulou P, Lazaridis K et al (2015) MuSK autoantibodies in myasthenia gravis detected by cell based assay\u2014a multinational study. J Neuroimmunol 284:10\u201317","journal-title":"J Neuroimmunol"},{"key":"8478_CR32","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1007\/s10072-013-1329-5","volume":"34","author":"W Wang","year":"2013","unstructured":"Wang W, Chen YP, Wang ZK, Wei DN, Yin L (2013) A cohort study on myasthenia gravis patients in China. Neurol Sci 34:1759\u20131764","journal-title":"Neurol Sci"},{"key":"8478_CR33","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/j.1365-2796.2007.01879.x","volume":"263","author":"XB Wang","year":"2008","unstructured":"Wang XB, Pirskanen R, Giscombe R, Lefvert AK (2008) Two SNPs in the promoter region of the CTLA-4 gene affect binding of transcription factors and are associated with human myasthenia gravis. J Intern Med 263:61\u201369","journal-title":"J Intern Med"},{"key":"8478_CR34","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/j.1651-2227.2011.02494.x","volume":"101","author":"S Ygberg","year":"2012","unstructured":"Ygberg S, Nilsson A (2012) The developing immune system\u2014from foetus to toddler. Acta Paediatr 101:120\u2013127","journal-title":"Acta Paediatr"},{"key":"8478_CR35","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1136\/jnnp.2006.100545","volume":"78","author":"X Zhang","year":"2007","unstructured":"Zhang X, Yang M, Xu J, Zhang M, Lang B, Wang W, Vincent A (2007) Clinical and serological study of myasthenia gravis in HuBei Province, China. J Neurol Neurosurg Psychiatry 78:386\u2013390","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8478_CR36","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/sji.12057","volume":"78","author":"S Zheng","year":"2013","unstructured":"Zheng S, Dou C, Xin N, Wang J, Wang J, Li P, Fu L, Shen X, Cui G, Dong R, Lu J, Zhang Y (2013) Expression of interleukin-22 in myasthenia gravis. Scand J Immunol 78:98\u2013107","journal-title":"Scand J Immunol"},{"key":"8478_CR37","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jaut.2013.12.004","volume":"52","author":"P Zisimopoulou","year":"2014","unstructured":"Zisimopoulou P, Evangelakou P, Tzartos J et al (2014) A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis. J Autoimmun 52:139\u2013145","journal-title":"J Autoimmun"}],"updated-by":[{"DOI":"10.1007\/s00415-019-09292-2","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2019,4,11]],"date-time":"2019-04-11T00:00:00Z","timestamp":1554940800000},"record-id":"20298"},{"DOI":"10.1007\/s00415-019-09292-2","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2019,4,11]],"date-time":"2019-04-11T00:00:00Z","timestamp":1554940800000}}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-017-8478-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-017-8478-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-017-8478-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T09:02:07Z","timestamp":1600333327000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-017-8478-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,31]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["8478"],"URL":"https:\/\/doi.org\/10.1007\/s00415-017-8478-z","relation":{"retraction":[{"id-type":"doi","id":"10.1007\/s00415-019-09292-2","asserted-by":"object"}]},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,31]]},"assertion":[{"value":"14 February 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2019","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Joint Editors-in-Chief have retracted this article [1] at the request of the University of Bergen and the Norwegian Board of Health Supervision.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2019","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Joint Editors-in-Chief have retracted this article [1] at the request of the University of Bergen and the Norwegian Board of Health Supervision.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Socrates J Tzartos has shares in the diagnostic laboratory Tzartos NeuroDiagnostics. All other authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}